pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 24·1 min read
save

Exclusive: UC Berkeley startup bets on jumping genes for GLP-1 gene therapy

The new generation of weight loss medicines does an unprecedented job of keeping off the pounds — if people stay on the drugs. Yet numerous studies suggest most of those who start taking GLP-1 drugs quit ...

Apr 24, 2026·read at Endpoints ↗

April 24, 2026 10:00 AM EDTUpdated 11 hours ago Cell/Gene TxIn FocusGLP-1 drugs Ex­clu­sive: UC Berke­ley start­up bets on jump­ing genes for GLP-1 gene ther­a­py Ryan Cross Senior Science Correspondent The new gen­er­a­tion of weight loss med­i­cines does an un­prece­dent­ed job of keep­ing off the pounds — if peo­ple stay on the drugs. Yet nu­mer­ous stud­ies … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
91 words · retrieved Apr 26
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor3Obesity2Gene Therapy (AAV)

related stories

  • Jul 21STAT+: Anthropic deepens work with rare disease drugsSTAT
  • Jul 20Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independenceBioSpace
  • Jun 30STAT+: Investors double down on Bain-backed startupSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 9Gilead and Merck’s latest trial success and flopSTAT